CN102743792B - 用于增强血管通路的方法和组合物 - Google Patents
用于增强血管通路的方法和组合物 Download PDFInfo
- Publication number
- CN102743792B CN102743792B CN201210246619.1A CN201210246619A CN102743792B CN 102743792 B CN102743792 B CN 102743792B CN 201210246619 A CN201210246619 A CN 201210246619A CN 102743792 B CN102743792 B CN 102743792B
- Authority
- CN
- China
- Prior art keywords
- cell
- implantable material
- graft
- cryopreservation
- implantable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
Abstract
Description
Claims (54)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69270805P | 2005-06-21 | 2005-06-21 | |
US60/692,708 | 2005-06-21 | ||
PCT/US2005/043967 WO2006062909A2 (en) | 2004-12-08 | 2005-12-06 | Methods and compositions for enhancing vascular access |
USPCT/US2005/043967 | 2005-12-06 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800279776A Division CN101257861B (zh) | 2005-06-21 | 2006-06-05 | 用于增强血管通路的方法和组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102743792A CN102743792A (zh) | 2012-10-24 |
CN102743792B true CN102743792B (zh) | 2014-09-24 |
Family
ID=39892157
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102362140A Pending CN101878757A (zh) | 2005-06-21 | 2006-06-05 | 用于增强血管通路的方法和组合物 |
CN201210246619.1A Expired - Fee Related CN102743792B (zh) | 2005-06-21 | 2006-06-05 | 用于增强血管通路的方法和组合物 |
CN2006800279776A Expired - Fee Related CN101257861B (zh) | 2005-06-21 | 2006-06-05 | 用于增强血管通路的方法和组合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102362140A Pending CN101878757A (zh) | 2005-06-21 | 2006-06-05 | 用于增强血管通路的方法和组合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800279776A Expired - Fee Related CN101257861B (zh) | 2005-06-21 | 2006-06-05 | 用于增强血管通路的方法和组合物 |
Country Status (10)
Country | Link |
---|---|
US (2) | US20090035346A1 (zh) |
EP (2) | EP2361591A3 (zh) |
JP (2) | JP5632580B2 (zh) |
CN (3) | CN101878757A (zh) |
AU (1) | AU2006262682B2 (zh) |
CA (2) | CA2818182C (zh) |
ES (1) | ES2541684T3 (zh) |
IL (2) | IL188263A (zh) |
SG (2) | SG161258A1 (zh) |
WO (1) | WO2007001744A2 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2605080A1 (en) | 2005-04-21 | 2006-11-02 | Massachusetts Institute Of Technology | Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs |
SG161258A1 (en) | 2005-06-21 | 2010-05-27 | Pervasis Therapeutics Inc | Methods and compositions for enhancing vascular access |
CN103230414A (zh) * | 2006-11-07 | 2013-08-07 | 夏尔再生医学公司 | 用于治疗和控制血管生成介导的疾病的材料和方法 |
WO2008057590A2 (en) * | 2006-11-07 | 2008-05-15 | Pervasis Therapeutics, Inc. | Methods and compositions for modulating tissue modeling |
WO2009097218A1 (en) * | 2008-01-28 | 2009-08-06 | Biomet 3I, Llc | Implant surface with increased hydrophilicity |
CN109172809A (zh) * | 2011-04-28 | 2019-01-11 | 阿布拉科斯生物科学有限公司 | 纳米颗粒组合物的血管内递送及其应用 |
CN102763642B (zh) * | 2012-08-14 | 2014-04-02 | 郑州赛英科干细胞技术有限公司 | 一种冷冻保护液以及冷冻保存人胎盘羊膜和绒毛膜的方法 |
WO2015181245A1 (en) * | 2014-05-27 | 2015-12-03 | Novahep Ab | Bioengineered allogeneic valve |
AU2016228986B2 (en) * | 2015-03-10 | 2021-02-04 | Stent Tek Limited | Surgical system, device and methods of use thereof for the percutaneous creation of an arteriovenous fistula (AVF) |
US11389622B1 (en) * | 2017-11-13 | 2022-07-19 | Simon B. Rayhanabad | Patch for providing dialysis |
WO2019152799A1 (en) | 2018-02-02 | 2019-08-08 | University Of Louisville Research Foundation, Inc. | Sutureless graft anastomotic quick connect system |
IL311092A (en) * | 2018-08-31 | 2024-04-01 | Wisconsin Alumni Res Found | Fabrication of vascular grafts seeded with arterial endothelial cells |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766584A (en) * | 1995-06-02 | 1998-06-16 | Massachusetts Institute Of Technology | Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells |
US6328762B1 (en) * | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
Family Cites Families (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4418691A (en) * | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
US4787900A (en) * | 1982-04-19 | 1988-11-29 | Massachusetts Institute Of Technology | Process for forming multilayer bioreplaceable blood vessel prosthesis |
US4820626A (en) * | 1985-06-06 | 1989-04-11 | Thomas Jefferson University | Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself |
IL78950A (en) | 1985-06-06 | 1991-12-15 | Univ Jefferson | Coating for prosthetic devices |
US4732155A (en) * | 1985-08-27 | 1988-03-22 | The Children's Medical Center Corporation | Implantable chemoattractant system |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US6309635B1 (en) * | 1986-11-20 | 2001-10-30 | Children's Medical Center Corp. | Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo |
US5736372A (en) * | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
US5759830A (en) * | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
US5073492A (en) * | 1987-01-09 | 1991-12-17 | The Johns Hopkins University | Synergistic composition for endothelial cell growth |
US5145769A (en) * | 1987-08-21 | 1992-09-08 | Cryolife Inc. | Method for cryopreserving blood vessels |
US5202120A (en) * | 1987-09-11 | 1993-04-13 | Case Western Reserve University | Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
US4945086A (en) | 1988-05-03 | 1990-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Smooth muscle cell growth inhibitor |
US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US5575815A (en) * | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
CH676195A5 (zh) * | 1988-10-07 | 1990-12-28 | Sulzer Ag | |
JPH03133901A (ja) * | 1989-10-19 | 1991-06-07 | Osaka Gas Co Ltd | 生体細胞の凍結保存方法 |
WO1991007154A1 (en) * | 1989-11-13 | 1991-05-30 | President And Fellows Of Harvard College | EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO |
US5527532A (en) * | 1989-11-13 | 1996-06-18 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
US5540928A (en) * | 1991-02-27 | 1996-07-30 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
CA2071137A1 (en) * | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
EP0591462B1 (en) | 1991-07-15 | 2003-04-16 | Oklahoma Medical Research Foundation | Universal donor cells |
US5336615A (en) | 1992-01-06 | 1994-08-09 | Yale University | Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity |
JPH0646840A (ja) * | 1992-08-04 | 1994-02-22 | Nippon Zenyaku Kogyo Kk | 細胞凍結保存液 |
US5399665A (en) * | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6491938B2 (en) * | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
GB9306449D0 (en) * | 1993-03-29 | 1993-05-19 | Nat Heart Research Fund | Tissue equivalents |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5645829A (en) * | 1993-06-18 | 1997-07-08 | Beth Israel Hospital Association | Mesothelial cell gene therapy |
US6176874B1 (en) * | 1993-10-18 | 2001-01-23 | Masschusetts Institute Of Technology | Vascularized tissue regeneration matrices formed by solid free form fabrication techniques |
US6608182B1 (en) * | 1994-03-08 | 2003-08-19 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 2 |
WO1995029713A1 (en) | 1994-04-29 | 1995-11-09 | W.L. Gore & Associates, Inc. | Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix |
US5834029A (en) * | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
US6911216B1 (en) * | 1994-10-12 | 2005-06-28 | Genzyme Corporation | Targeted delivery via biodegradable polymers |
AU700903B2 (en) * | 1994-10-12 | 1999-01-14 | Focal, Inc. | Targeted delivery via biodegradable polymers |
US5914268A (en) * | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US6281015B1 (en) * | 1994-12-16 | 2001-08-28 | Children's Medical Center Corp. | Localized delivery of factors enhancing survival of transplanted cells |
US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
US5855610A (en) * | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
US6615071B1 (en) * | 1995-09-20 | 2003-09-02 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US5897987A (en) * | 1996-03-25 | 1999-04-27 | Advanced Reproduction Technologies, Inc. | Use of arabinogalactan in cell cryopreservation media |
US6886568B2 (en) * | 1998-04-08 | 2005-05-03 | The Johns Hopkins University | Method for fabricating cell-containing implants |
AU766693B2 (en) * | 1998-11-24 | 2003-10-23 | Emory University | Transgenic circulating endothelial cells |
US6387116B1 (en) * | 1999-06-30 | 2002-05-14 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
WO2001062241A1 (en) * | 2000-02-23 | 2001-08-30 | Smithkline Beecham Corporation | Method for the prevention or reduction of vascular access dysfunction |
CA2403218C (en) * | 2000-03-13 | 2011-10-18 | Biocure, Inc. | Embolic compositions |
WO2001068158A1 (en) * | 2000-03-15 | 2001-09-20 | Orbus Medical Technologies Inc. | Coating that promotes endothelial cell adherence |
JP4204784B2 (ja) | 2000-03-24 | 2009-01-07 | 株式会社メニコン | 組織等価物の凍結保存方法および凍結保存された組織等価物 |
US6506398B1 (en) * | 2000-04-28 | 2003-01-14 | Hosheng Tu | Device for treating diabetes and methods thereof |
WO2001095717A2 (en) * | 2000-06-09 | 2001-12-20 | Organ Recovery Systems | Cryopreservation method using cryoprotective composition of propanediol and a vehicle solution |
WO2002007749A2 (en) | 2000-07-21 | 2002-01-31 | Board Of Regents, The University Of Texas System | Device providing regulated growth factor delivery for the regeneration of peripheral nerves |
WO2002028387A1 (en) * | 2000-10-03 | 2002-04-11 | Oncopharmaceutical, Inc. | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
JP2002200161A (ja) * | 2000-10-24 | 2002-07-16 | Menicon Co Ltd | 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物 |
US6565601B2 (en) * | 2000-11-15 | 2003-05-20 | Micro Therapeutics, Inc. | Methods for vascular reconstruction of diseased arteries |
WO2002058588A2 (en) * | 2000-12-27 | 2002-08-01 | Ortec International, Inc. | Processes for making cryopreserved composite living constructs and products resulting therefrom |
PT2314293T (pt) * | 2001-01-16 | 2017-04-11 | Vascular Therapies Llc | Dispositivo implantável que contém material de matriz reabsorvível e rapamicina para prevenir ou tratar doenças vasuloproliferativas |
US6723131B2 (en) | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
AU2002330131A1 (en) | 2001-09-28 | 2003-04-07 | Goldberg, Eugene, P. | Biopolymer and biopolymer-cell compositions for nerve tissue repair |
US7297540B2 (en) * | 2002-01-15 | 2007-11-20 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs |
US20040047843A1 (en) * | 2002-02-12 | 2004-03-11 | Uab Research Foundation | Method for spinal cord reconnection |
AU2003223416A1 (en) * | 2002-03-25 | 2003-10-13 | Condros, Inc. | Tissue analogs for in vitro testing and method of use therefor |
US20050008629A1 (en) * | 2002-05-08 | 2005-01-13 | Interpore Orthopaedics, A Delaware Corporation | Encapsulated AGF cells |
JP2005537822A (ja) * | 2002-06-28 | 2005-12-15 | ノバルティス アクチエンゲゼルシャフト | 有機化合物の使用 |
FR2845691B1 (fr) * | 2002-10-10 | 2004-12-10 | Centre Nat Rech Scient | Nouvelles cellules endotheliales, anticorps diriges contre ces cellules et leur utilisation, notamment pour le criblage de substances inhibant l'angiogenese |
US20040156878A1 (en) * | 2003-02-11 | 2004-08-12 | Alireza Rezania | Implantable medical device seeded with mammalian cells and methods of treatment |
WO2004111207A1 (en) * | 2003-06-09 | 2004-12-23 | Centelion | Multicellular in vitro model of angiogenesis and methods for using the same |
WO2005003317A2 (en) * | 2003-07-01 | 2005-01-13 | Regents Of The University Of Minnesota | Engineered blood vessels |
GB0322789D0 (en) * | 2003-09-30 | 2003-10-29 | Lifeforce Group Plc | Blood pack for leukocyte banking |
WO2005052138A1 (en) * | 2003-11-19 | 2005-06-09 | Wisconsin Alumni Research Foundation | Cryopreservation of pluripotent stem cells |
WO2005072417A2 (en) * | 2004-01-27 | 2005-08-11 | The Ohio State University Research Foundation | Vascular endothelial growth factors and methods of their use |
DE602005027557D1 (de) * | 2004-04-23 | 2011-06-01 | Bioe Llc | Mehrfachlinien-vorläuferzellen |
FR2869533B1 (fr) | 2004-05-03 | 2006-07-28 | Sedat Sa | Seringue pour interventions medicales et necessaire de reconstitution de substances extemporanees comportant une telle seringue |
US7842304B2 (en) | 2004-10-29 | 2010-11-30 | Nexeon Medsystems, Inc. | Methods and apparatus for treating an injured nerve pathway |
EP1824526B1 (en) * | 2004-12-08 | 2009-12-02 | Pervasis Therapeutics, Inc. | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
WO2006062871A2 (en) | 2004-12-08 | 2006-06-15 | Pervasis Therapeutics, Inc. | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
WO2006062909A2 (en) * | 2004-12-08 | 2006-06-15 | Pervasis Therapeutics, Inc. | Methods and compositions for enhancing vascular access |
CA2605080A1 (en) | 2005-04-21 | 2006-11-02 | Massachusetts Institute Of Technology | Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs |
GB0509845D0 (en) | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Preparation of therapeutic foam |
SG161258A1 (en) | 2005-06-21 | 2010-05-27 | Pervasis Therapeutics Inc | Methods and compositions for enhancing vascular access |
CN101384704B (zh) | 2005-10-12 | 2012-02-08 | 细胞生物工程公司 | 可再吸收的角膜扣状体 |
US7882863B2 (en) * | 2005-10-19 | 2011-02-08 | Cd Solutions, Llc | Apparatus and method for mixing and transferring medications |
US7743799B2 (en) * | 2005-11-07 | 2010-06-29 | Industrie Borta S.p.A. | Vented safe handling vial adapter |
-
2006
- 2006-06-05 SG SG201002482-6A patent/SG161258A1/en unknown
- 2006-06-05 EP EP20110001333 patent/EP2361591A3/en not_active Withdrawn
- 2006-06-05 ES ES06772165.4T patent/ES2541684T3/es active Active
- 2006-06-05 CN CN2010102362140A patent/CN101878757A/zh active Pending
- 2006-06-05 CN CN201210246619.1A patent/CN102743792B/zh not_active Expired - Fee Related
- 2006-06-05 CN CN2006800279776A patent/CN101257861B/zh not_active Expired - Fee Related
- 2006-06-05 WO PCT/US2006/021755 patent/WO2007001744A2/en active Application Filing
- 2006-06-05 CA CA 2818182 patent/CA2818182C/en not_active Expired - Fee Related
- 2006-06-05 CA CA 2612751 patent/CA2612751A1/en not_active Abandoned
- 2006-06-05 JP JP2008518189A patent/JP5632580B2/ja not_active Expired - Fee Related
- 2006-06-05 US US11/922,729 patent/US20090035346A1/en not_active Abandoned
- 2006-06-05 EP EP20060772165 patent/EP1901680B1/en not_active Not-in-force
- 2006-06-05 SG SG2013075387A patent/SG195537A1/en unknown
- 2006-06-05 AU AU2006262682A patent/AU2006262682B2/en not_active Ceased
-
2007
- 2007-12-19 IL IL188263A patent/IL188263A/en not_active IP Right Cessation
-
2012
- 2012-06-12 JP JP2012133043A patent/JP2012166084A/ja not_active Withdrawn
- 2012-07-05 IL IL220806A patent/IL220806A/en not_active IP Right Cessation
- 2012-11-02 US US13/667,227 patent/US9023377B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766584A (en) * | 1995-06-02 | 1998-06-16 | Massachusetts Institute Of Technology | Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells |
US6328762B1 (en) * | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
Also Published As
Publication number | Publication date |
---|---|
CN101257861A (zh) | 2008-09-03 |
AU2006262682B2 (en) | 2012-07-05 |
JP2012166084A (ja) | 2012-09-06 |
CN101878757A (zh) | 2010-11-10 |
WO2007001744B1 (en) | 2007-12-21 |
AU2006262682A1 (en) | 2007-01-04 |
CA2818182A1 (en) | 2007-01-04 |
ES2541684T3 (es) | 2015-07-23 |
US20130210142A1 (en) | 2013-08-15 |
CN102743792A (zh) | 2012-10-24 |
US9023377B2 (en) | 2015-05-05 |
IL188263A (en) | 2014-05-28 |
US20090035346A1 (en) | 2009-02-05 |
CA2612751A1 (en) | 2007-01-04 |
IL188263A0 (en) | 2009-02-11 |
EP2361591A3 (en) | 2011-12-21 |
JP5632580B2 (ja) | 2014-11-26 |
EP2361591A2 (en) | 2011-08-31 |
SG161258A1 (en) | 2010-05-27 |
WO2007001744A2 (en) | 2007-01-04 |
IL220806A0 (en) | 2012-08-30 |
CN101257861B (zh) | 2012-12-05 |
WO2007001744A3 (en) | 2007-10-04 |
SG195537A1 (en) | 2013-12-30 |
IL220806A (en) | 2014-05-28 |
CA2818182C (en) | 2015-04-14 |
EP1901680B1 (en) | 2015-04-15 |
JP2008546406A (ja) | 2008-12-25 |
EP1901680A2 (en) | 2008-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102743792B (zh) | 用于增强血管通路的方法和组合物 | |
CN101940801B (zh) | 增强血管通路的方法和组合物 | |
CN101141988B (zh) | 增强血管通路的方法和组合物 | |
US20100204783A1 (en) | Methods and compositions for enhancing vascular access | |
CN101583367A (zh) | 用于治疗和控制血管生成介导的疾病的材料和方法 | |
WO2006062909A2 (en) | Methods and compositions for enhancing vascular access | |
AU2012238220B2 (en) | Methods and compositions for enhancing vascular access | |
AU2011211370B2 (en) | Methods and compositions for enhancing vascular access |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHIRE REGENERATIVE MEDICAL COMPANY Free format text: FORMER OWNER: PERVASIS THERAPEUTICS INC. Effective date: 20130403 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130403 Address after: American California Applicant after: Pervasis Therapeutics Inc. Address before: Massachusetts, USA Applicant before: Pervasis Therapeutics Inc. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1174859 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1174859 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140924 Termination date: 20200605 |
|
CF01 | Termination of patent right due to non-payment of annual fee |